Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients. Benmerzoug S, Chevalier MF, Verardo M, Nguyen S, et al. Eur Urol Focus 2021 Jun 16. pii: S2405-4569(21)00163.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Benmerzoug S, Chevalier MF, Verardo M, Nguyen S, et al. Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients. Eur Urol Focus 2021 Jun 16. pii: S2405-4569(21)00163.
PMID: 34147404